tiprankstipranks
Alkermes (ALKS)
NASDAQ:ALKS
US Market
ALKS
Alkermes
RESEARCH TOOLSreports
Want to see ALKS full AI Analyst Report?

Alkermes (ALKS) Stock News & Sentiment

627 Followers
Alkermes: Positive Alixorexton Phase 2 Data in Narcolepsy Type 1 Support Advancement to Phase 3 and Reinforce Buy Rating
Premium
Ratings
Alkermes: Positive Alixorexton Phase 2 Data in Narcolepsy Type 1 Support Advancement to Phase 3 and Reinforce Buy Rating
14d ago
ALKS
Alkermes Advances ALKS 2680 Into Phase 3 for Narcolepsy Type 1: What Investors Should Watch
Premium
Company Announcements
Alkermes Advances ALKS 2680 Into Phase 3 for Narcolepsy Type 1: What Investors Should Watch
2M ago
ALKS
Alkermes’ ALKS 2680 Narcolepsy Study Completion: What Investors Should Watch Next
Premium
Company Announcements
Alkermes’ ALKS 2680 Narcolepsy Study Completion: What Investors Should Watch Next
2M ago
ALKS
Balanced Risk-Reward Amid Softer 2026 Outlook Keeps Rating at Hold
Premium
Ratings
Balanced Risk-Reward Amid Softer 2026 Outlook Keeps Rating at Hold
2M ago
ALKS
Alkermes Earnings Call: Growth, LUMRIZE and New Risks
Premium
Company Announcements
Alkermes Earnings Call: Growth, LUMRIZE and New Risks
2M ago
ALKS
Alkermes: Durable Commercial Portfolio, Alixorexton Catalyst, and Orderly CEO Transition Support Buy Rating
Premium
Ratings
Alkermes: Durable Commercial Portfolio, Alixorexton Catalyst, and Orderly CEO Transition Support Buy Rating
2M ago
ALKS
Alkermes Announces CEO Succession and Leadership Transition Plan
Premium
Company Announcements
Alkermes Announces CEO Succession and Leadership Transition Plan
2M ago
8K
ALKS
More ALKS News >

ALKS News on the Web

Alkermes: Positive Alixorexton Phase 2 Data in Narcolepsy Type 1 Support Advancement to Phase 3 and Reinforce Buy Rating
TipRanks News
Bullish
Alkermes to present additional data from Vibrance-1 Phase 2 alixorexton study
TipRanks News
Bullish
Alkermes announces publication of 56-week post hoc analysis of Lybalvi
TipRanks News
Bullish
Analysts Are Bullish on Top Healthcare Stocks: InflaRx (IFRX), Pfizer (PFE)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Wuxi Biologics (Cayman) (OtherWXIBF) and Alkermes (ALKS)
TipRanks News
Bullish
Alkermes price target raised to $36 from $34 at BofA
TipRanks News
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alkermes (ALKS), ProQR (PRQR) and Simulations Plus (SLP)
TipRanks News
Bullish
Alkermes price target lowered to $44 from $45 at RBC Capital
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
ALKS
Sector Average
Media Buzz
This Week4 articles
Weekly Average5.75 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ALKS’s Media Buzz Sentiment?
4 articles about ALKS were published this week. In an average week, 5.75 articles are published.
    What is ALKS’s weekly average amount of articles?
    In an average week, 5.75 articles about ALKS are published.
      What is ALKS’s News Sentiment?
      100% of articles about ALKS were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week